托法西替尼修复了GM-CSF重编程的RA巨细胞中的炎症和线粒体失调
Neha Satoeya1,2, Stephanie R Zack1,2, Osama Al Zoubi1,2
1Jesse Brown VA Medical Center, Chicago, IL, USA.
Cellular & molecular immunology
|March 4, 2026
概括
托法西提尼有效向风湿性关节炎 (RA) 中的GM-CSF巨细胞,通过抑制STAT5信号,逆转炎症和线粒体损伤. 与其他疗法不同,它恢复了这些细胞中的调节性表型,为RA患者提供了一个有前途的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 细胞生物学 细胞生物学
背景情况:
- 类风湿性关节炎 (RA) 表现出多种不同的内型,挑战治疗疗效.
- 颗粒细胞巨细胞殖民地刺激因子 (GM-CSF) 和它的受体 (GM-CSFRα) 在RA突巨细胞 (MΦs) 中普遍存在,并与疾病进展有关.
- 现有的抗TNFi和抗IL6R等疗法未能抑制GM-CSF/GM-CSFRα信号传递.
研究的目的:
- 研究针对RA中的GM-CSF功能的替代治疗策略.
- 描述RA中GM-CSF-MΦs的代谢和炎症概况.
- 在临床前的RA模型中评估代谢抑制剂和托法西提尼布的疗效.
主要方法:
- 分析RA血液和突组织.
- 用复合I抑制剂和葡萄糖吸收阻断剂 (HK2i) 治疗GM-CSF-MΦs.
- 评估托法西替尼对GM-CSFRα表达,STAT5信号和MΦ表型的影响.
- 在临床前的RA模型中评估GM-CSF过度表达.
主要成果:
- 在RA中,GM-CSF-MΦs表现出明显的炎症和代谢特征,并具有线粒体功能障碍.
- 代谢抑制剂 (复合II,HK2i) 在改变GM-CSF-MΦ表型方面表现出有限的有效性.
- 托法西替尼有效降低了GM-CSFRα的调节,抑制了STAT5信号传输,并逆转了MΦ重编程,氧化应激和线粒体分裂.
- 托法西替尼在临床前模型中通过纠正GM-CSF诱导的炎症和代谢失调来证明有效性.
结论:
- 抗TNFi,抗IL6R和代谢向疗法对于RA的GM-CSF-MΦ病理不够.
- 托法西提尼布对STAT5信号的抑制提供了一种有效的策略,以抵消在RA中GM-CSF-MΦ驱动的炎症和线粒体功能障碍.
- 托法西替尼恢复调节性MΦ标记物,并重新平衡氧化酸化,为RA提供了可行的治疗选择.
更多相关视频
相关概念视频
T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
670
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670
Inflammatory Response
17.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.7K
TGF - β Signaling Pathway
10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
8.5K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
8.5K


